Art

J-GLOBAL ID：202002257142582055   Reference number：20A0772102

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial

視神経脊髄炎スペクトラム障害(RIN-1研究)におけるリツキシマブの安全性と有効性:多施設無作為化二重盲検プラセボ対照試験【JST・京大機械翻訳】

Author (15)： Tahara Masayuki (Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan) ,  Oeda Tomoko (Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan) ,  Okada Kazumasa (Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Japan) ,  Kiriyama Takao (Department of Neurology, Nara Medical University School of Medicine, Nara, Japan) ,  Ochi Kazuhide (Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan) ,  Maruyama Hirofumi (Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan) ,  Fukaura Hikoaki (Department of Neurology, Saitama Medical University, Kawagoe, Japan) ,  Nomura Kyoichi (Department of Neurology, Saitama Medical University, Kawagoe, Japan) ,  Shimizu Yuko (Department of Neurology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Mori Masahiro (Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan) ,  Nakashima Ichiro (Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan) ,  Misu Tatsuro (Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Umemura Atsushi (Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan) ,  Yamamoto Kenji (Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan) ,  Sawada Hideyuki (Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan)
Material： Lancet Neurology
Volume： 19  Issue： 4  Page： 298-306  Publication year： 2020 
JST Material Number： W3105A  ISSN： 1474-4422  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Pharmacological prevention aga...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0772102&from=J-GLOBAL&jstjournalNo=W3105A") }}

Thesaurus term： diplopia ,  clinical trial ,  spectrum ,  stratification ,  maintenance therapy ,  antibody ,  pharmacology ,  *placebo ,  visual evoked potential ,  intravenous administration ,  logarithm ,  CAE ,  immunosuppressant ,  uterine tumor ,  *double blind test

JST classification (4)： Neurologic diagnosis  (GN02000H) ,  Nervous system diseases  (GN03000O) ,  Immunologic diseases,allergic diseases in general.  (GD04010C) ,  Drug therapy(=pharmacotherapy)for nervous system diseases  (GN05020Y)

Terms in the title (8)： 視神経脊髄炎スペクトラム障害 ,  研究 ,  リツキシマブ ,  安全性 ,  有効性 ,  施設 ,  二重盲検 ,  プラセボ